Sikhulile Moyo

Predictors of HIV seroconversion in Botswana: machine learning analysis in a representative, population-based HIV incidence cohort.

Cui Y, Moyo S, Pretorius Holme M, Hurwitz KE, Choga W, Bennett K, Chakalisa U, San JE, Manyake K, Kgathi C, Diphoko A, Gaseitsiwe S, Gaolathe T, Essex M, Tchetgen Tchetgen E, Makhema JM, Lockman S.

AIDS. 2024 Nov 04. PMID: 39497537

Infectious Morbidity and All-cause Mortality of Infants HIV-exposed Uninfected Compared to Infants HIV-unexposed Uninfected in Botswana.

Dubois MM, Jao J, Sun S, Legbedze J, Schenkel S, Mmasa N, Kgole SW, Masasa G, Happel AU, Iwase SC, Haghighat R, Moyo S, Sharma TS, Edlefsen PT, Shao D, Jaspan H, Powis KM.

Pediatr Infect Dis J. 2024 Oct 31. PMID: 39486012

Low prevalence of archived integrase strand transfer inhibitors resistance associated mutations in Botswana before the roll out of dolutegravir based first line antiretroviral therapy.

Maruapula D, Ditshwanelo D, Pema MN, Bareng OT, Choga WT, Moraka NO, Mokgethi PT, Seatla KK, Koofhethile CK, Zuze BJ, Gaolathe T, Pretorius-Holme M, Lebani K, Makhema J, Novitsky V, Shapiro R, Lockman S, Moyo S, Gaseitsiwe S.

Front Microbiol. 2024. 15:1482348. PMID: 39512940

Patterns of HIV-1 Drug Resistance Observed Through Geospatial Analysis of Routine Diagnostic Testing in KwaZulu-Natal, South Africa.

Gounder L, Khan A, Manasa J, Lessells R, Tomita A, Pillay M, Manyana SC, Govender S, Francois KL, Moodley P, Msomi N, Govender K, Parboosing R, Moyo S, Naidoo K, Chimukangara B.

Viruses. 2024 Oct 19. 16(10). PMID: 39459966

Phylodynamic Structure in the Botswana HIV Epidemic.

Kotokwe K, Nascimento FF, Moyo S, Gaseitsiwe S, Holme MP, Makhema J, Essex M, Novitsky V, Volz E, Ragonnet-Cronin M.

Res Sq. 2024 Oct 18. PMID: 39483888

High-risk human papillomavirus diversity among indigenous women of western Botswana with normal cervical cytology and dysplasia.

Rantshabeng PS, Tsima BM, Ndlovu AK, Motlhatlhedi K, Sharma K, Masole CB, Moraka NO, Motsumi K, Maoto-Mokote AKT, Eshetu AB, Tawe L, Gaolathe T, Moyo S, Kyokunda LT.

BMC Infect Dis. 2024 Oct 15. 24(1):1163. PMID: 39407130

Hepatitis Delta Virus Clade 8 Is the Predominant Clade Circulating in Botswana amongst People Living with HIV.

Baruti K, Choga WT, Motshosi PC, Phinius BB, Phakedi B, Bhebhe LN, Mpebe GGA, Tsayang CD, Ratsoma T, Gaolathe T, Mosepele M, Makhema J, Shapiro R, Lockman S, Moyo S, Jongman M, Anderson M, Gaseitsiwe S.

Viruses. 2024 Oct 04. 16(10). PMID: 39459902

Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study.

Jao J, Bonner LB, Dobinda K, Powis KM, Sun S, Legbedze J, Mmasa KN, Makhema J, Mmalane M, Kgole S, Masasa G, Moyo S, Gerschenson M, Mohammed T, Abrams EJ, Kurland IJ, Geffner ME.

Clin Infect Dis. 2024 Sep 26. 79(3):727-733. PMID: 38531012

No impact of COVID-19 at delivery on maternal mortality or infant adverse birth outcomes in Botswana during the Omicron era.

Banga J, Jackson-Gibson M, Diseko M, Caniglia EC, Mayondi G, Mabuta J, Luckett R, Moyo S, Smith-Lawrence P, Mosepele M, Lockman S, Makhema J, Zash R, Shapiro R.

PLoS One. 2024. 19(9):e0310980. PMID: 39321175

Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial.

Bishop MD, Korutaro V, Boyce CL, Beck IA, Styrchak SM, Knowles K, Ziemba L, Brummel SS, Coletti A, Jean-Philippe P, Chakhtoura N, Vhembo T, Cassim H, Owor M, Fairlie L, Moyo S, Chinula L, Lockman S, Frenkel LM.

J Acquir Immune Defic Syndr. 2024 Aug. 96(4):385-392. PMID: 39175843